submitter_follow_up_id,program_id,submitter_donor_id,submitter_primary_diagnosis_id,submitter_treatment_id,date_of_followup,disease_status_at_followup,relapse_type,date_of_relapse,method_of_progression_status,anatomic_site_progression_or_recurrence
FOLLOW_UP_0001,SYNTH_01,DONOR_0001,DIAG_0001,,"{'day_interval': 1977, 'month_interval': 64}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 502, 'month_interval': 16}",Assessment of symptom control (procedure),
FOLLOW_UP_0002,SYNTH_01,DONOR_0002,,TREATMENT_0003,"{'day_interval': 826, 'month_interval': 27}",,Local recurrence and distant metastasis,,Tumor marker measurement (procedure),
FOLLOW_UP_0003,SYNTH_01,DONOR_0003,,,"{'day_interval': 3854, 'month_interval': 126}",Loco-regional progression,Local recurrence,"{'day_interval': 2945, 'month_interval': 96}",Physical examination procedure (procedure),
FOLLOW_UP_0004,SYNTH_01,DONOR_0004,DIAG_0004,,"{'day_interval': 3689, 'month_interval': 121}",Distant progression,Progression (liquid tumours),"{'day_interval': 3596, 'month_interval': 118}",Physical examination procedure (procedure),
FOLLOW_UP_0005,SYNTH_01,DONOR_0005,,TREATMENT_0009,"{'day_interval': 791, 'month_interval': 25}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 411, 'month_interval': 13}",Histopathology test (procedure),
FOLLOW_UP_0006,SYNTH_01,DONOR_0006,,,"{'day_interval': 1046, 'month_interval': 34}",,Local recurrence and distant metastasis,,Tumor marker measurement (procedure),
FOLLOW_UP_0007,SYNTH_01,DONOR_0007,DIAG_0007,,"{'day_interval': 12278, 'month_interval': 403}",Complete remission,Local recurrence and distant metastasis,,Tumor marker measurement (procedure),
FOLLOW_UP_0008,SYNTH_01,DONOR_0008,,TREATMENT_0015,"{'day_interval': 1068, 'month_interval': 35}",Complete remission,Local recurrence and distant metastasis,,,
FOLLOW_UP_0009,SYNTH_01,DONOR_0009,,,,No evidence of disease,Local recurrence,,Physical examination procedure (procedure),
FOLLOW_UP_0010,SYNTH_01,DONOR_0010,DIAG_0010,,"{'day_interval': 6590, 'month_interval': 216}",Stable,Local recurrence and distant metastasis,,Imaging (procedure),
FOLLOW_UP_0011,SYNTH_02,DONOR_0021,,TREATMENT_0041,"{'day_interval': 819, 'month_interval': 26}",Complete remission,Progression (liquid tumours),,Tumor marker measurement (procedure),
FOLLOW_UP_0012,SYNTH_02,DONOR_0022,,,"{'day_interval': 4186, 'month_interval': 137}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 2653, 'month_interval': 87}",Laboratory data interpretation (procedure),
FOLLOW_UP_0013,SYNTH_02,DONOR_0023,DIAG_0023,,,No evidence of disease,Local recurrence and distant metastasis,,Histopathology test (procedure),
FOLLOW_UP_0014,SYNTH_02,DONOR_0024,,TREATMENT_0047,,Distant progression,Progression (liquid tumours),"{'day_interval': 306, 'month_interval': 10}",Histopathology test (procedure),
FOLLOW_UP_0015,SYNTH_02,DONOR_0025,,,"{'day_interval': 3255, 'month_interval': 106}",,Progression (liquid tumours),,Assessment of symptom control (procedure),
FOLLOW_UP_0016,SYNTH_02,DONOR_0026,DIAG_0026,,"{'day_interval': 7774, 'month_interval': 255}",Relapse or recurrence,Progression (liquid tumours),,,
FOLLOW_UP_0017,SYNTH_02,DONOR_0027,,TREATMENT_0053,"{'day_interval': 877, 'month_interval': 28}",No evidence of disease,Progression (liquid tumours),,Assessment of symptom control (procedure),
FOLLOW_UP_0018,SYNTH_02,DONOR_0028,,,"{'day_interval': 405, 'month_interval': 13}",Distant progression,Distant recurrence/metastasis,"{'day_interval': 327, 'month_interval': 10}",Imaging (procedure),
FOLLOW_UP_0019,SYNTH_02,DONOR_0029,DIAG_0029,,"{'day_interval': 7987, 'month_interval': 262}",Complete remission,Progression (liquid tumours),,Physical examination procedure (procedure),
FOLLOW_UP_0020,SYNTH_02,DONOR_0030,,TREATMENT_0059,"{'day_interval': 753, 'month_interval': 24}",,Progression (liquid tumours),,Tumor marker measurement (procedure),
FOLLOW_UP_0021,SYNTH_03,DONOR_0041,,,"{'day_interval': 1444, 'month_interval': 47}",Distant progression,Progression (liquid tumours),"{'day_interval': 789, 'month_interval': 25}",,
FOLLOW_UP_0022,SYNTH_03,DONOR_0042,DIAG_0042,,"{'day_interval': 1434, 'month_interval': 47}",Partial remission,Biochemical progression,,Physical examination procedure (procedure),
FOLLOW_UP_0023,SYNTH_03,DONOR_0043,,TREATMENT_0085,"{'day_interval': 726, 'month_interval': 23}",Progression not otherwise specified,Distant recurrence/metastasis,"{'day_interval': 215, 'month_interval': 7}",Histopathology test (procedure),
FOLLOW_UP_0024,SYNTH_03,DONOR_0044,,,"{'day_interval': 1319, 'month_interval': 43}",,Biochemical progression,,Laboratory data interpretation (procedure),
FOLLOW_UP_0025,SYNTH_03,DONOR_0045,DIAG_0045,,"{'day_interval': 1436, 'month_interval': 47}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 1060, 'month_interval': 34}",Tumor marker measurement (procedure),
FOLLOW_UP_0026,SYNTH_03,DONOR_0046,,TREATMENT_0091,"{'day_interval': 558, 'month_interval': 18}",Complete remission,Local recurrence,,Assessment of symptom control (procedure),
FOLLOW_UP_0027,SYNTH_03,DONOR_0047,,,"{'day_interval': 1749, 'month_interval': 57}",Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 704, 'month_interval': 23}",Laboratory data interpretation (procedure),
FOLLOW_UP_0028,SYNTH_03,DONOR_0048,DIAG_0048,,"{'day_interval': 831, 'month_interval': 27}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 246, 'month_interval': 8}",,
FOLLOW_UP_0029,SYNTH_03,DONOR_0049,,TREATMENT_0097,"{'day_interval': 605, 'month_interval': 19}",Distant progression,Local recurrence,"{'day_interval': 304, 'month_interval': 9}",,
FOLLOW_UP_0030,SYNTH_03,DONOR_0050,,,"{'day_interval': 6363, 'month_interval': 209}",Complete remission,Progression (liquid tumours),,Imaging (procedure),
FOLLOW_UP_0031,SYNTH_04,DONOR_0061,DIAG_0061,,"{'day_interval': 1502, 'month_interval': 49}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 1472, 'month_interval': 48}",Assessment of symptom control (procedure),
FOLLOW_UP_0032,SYNTH_04,DONOR_0062,,TREATMENT_0123,,Relapse or recurrence,Local recurrence,,Assessment of symptom control (procedure),
FOLLOW_UP_0033,SYNTH_04,DONOR_0063,,,"{'day_interval': 3525, 'month_interval': 115}",Partial remission,Biochemical progression,,,
FOLLOW_UP_0034,SYNTH_04,DONOR_0064,DIAG_0064,,"{'day_interval': 5555, 'month_interval': 182}",Complete remission,Progression (liquid tumours),,,
FOLLOW_UP_0035,SYNTH_04,DONOR_0065,,TREATMENT_0129,"{'day_interval': 982, 'month_interval': 32}",Stable,Progression (liquid tumours),,Imaging (procedure),
FOLLOW_UP_0036,SYNTH_04,DONOR_0066,,,"{'day_interval': 988, 'month_interval': 32}",,Distant recurrence/metastasis,,Laboratory data interpretation (procedure),
FOLLOW_UP_0037,SYNTH_04,DONOR_0067,DIAG_0067,,"{'day_interval': 526, 'month_interval': 17}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 441, 'month_interval': 14}",Imaging (procedure),
FOLLOW_UP_0038,SYNTH_04,DONOR_0068,,TREATMENT_0135,,,Local recurrence and distant metastasis,,Imaging (procedure),
FOLLOW_UP_0039,SYNTH_04,DONOR_0069,,,"{'day_interval': 510, 'month_interval': 16}",Relapse or recurrence,Biochemical progression,,Tumor marker measurement (procedure),
FOLLOW_UP_0040,SYNTH_04,DONOR_0070,DIAG_0070,,,Relapse or recurrence,Local recurrence,,Tumor marker measurement (procedure),
FOLLOW_UP_NULL_0001,SYNTH_01,DONOR_NULL_0001,,TREATMENT_NULL_0001,,,,,,
FOLLOW_UP_NULL_0002,SYNTH_01,DONOR_NULL_0002,,,"{'day_interval': 1911, 'month_interval': 62}",,,,,
FOLLOW_UP_ALL_0001,SYNTH_01,DONOR_ALL_0001,DIAG_ALL_0001,,"{'day_interval': 5471, 'month_interval': 179}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 2929, 'month_interval': 96}",,
FOLLOW_UP_ALL_0002,SYNTH_01,DONOR_ALL_0002,,TREATMENT_ALL_0003,"{'day_interval': 828, 'month_interval': 27}",,Distant recurrence/metastasis,,Tumor marker measurement (procedure),
